The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

The Centers for Medicare & Medicaid Services (CMS) announced that Botox is among 15 prescription drugs newly added to the ...

List includes medications for diabetes, cancer, arthritis, and more ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...